Jpmorgan Chase & Co »

Accelerate Diagnostics Inc - US shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Accelerate Diagnostics Inc - US (AXDX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Accelerate Diagnostics Inc - US

Tip: Access up to 7 years of quarterly data

All positions including Accelerate Diagnostics Inc - US held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Accelerate Diagnostics Inc - US by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $44 11 4.00
2023-09-30 $45 8 5.71

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Accelerate Diagnostics Inc - US

Griffin Asset Management
Vanguard Group
Peter B. Cannell & Co
Oracle Investment Management
TCI Wealth Advisors
Warberg Asset Management
Ironwood Wealth Management
Citadel Advisors
Tudor Investment Corporation
Millennium Management
Tejara Capital
Hanson McClain Advisors
Thompson Investment Management
UBS Group
Royal Bank of Canada

View all funds holding Accelerate Diagnostics Inc - US